• Audion Therapeutics Raises Funds to Advance the Development of Hearing Loss Treatment

    AMSTERDAM, The Netherlands, Sept. 7, 2015 (GLOBE NEWSWIRE) —¬†Audion Therapeutics¬†announced today that it has received a 2.5 million Euro Series B investment from INKEF Capital, a Netherlands based venture capital firm. In addition, Audion announced that, together with a strong international consortium of development partners, it was awarded a 5.8 million Euro grant through the Horizon 2020 program. The combined funds of 8.3 million Euro enable Audion to progress its lead program targeting sensorineural hearing loss to clinical Proof of Concept. Rolf Jan Rutten, CEO of Audion commented on these important milestones: “The investment from INKEF Capital and the receipt […]

  • Audion Announces Investment and Licensing Deal With Lilly To Develop Hearing Loss Treatments

    Amsterdam, the Netherlands, February 10, 2014 Audion Therapeutics¬†announced today that it has received a Series A investment from Eli Lilly and Company to enable the company to progress its programs targeting sensorineural hearing loss. As part of the investment, the parties also entered into a licensing agreement that gives Audion the rights to certain Lilly compounds that can be developed to potentially treat hearing loss by hair cell regeneration. Under the terms of the license, Lilly has an option to reacquire these rights upon successful clinical Proof of Concept. Financial terms were not disclosed. Following the investment, Mr. Shaun Hawkins, […]

© Copyright Company Name 2011. All rights reserved.